LUNG

Pulmonx Corp. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website ulmonx.com
Employees(FY) 269
ISIN US7458481014

Performance

+1.65%

+2.5%

-28.32%

+4.33%

-51.76%

YTD

-49.17%

Profile

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.

Advanced Technical Analysis

Technical Analysis of LUNG 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of LUNG

Stock Rank

Recent News & Updates

2024-11-20 20:55
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?(Yahoo Finance)
2024-11-20 03:05
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference(Globenewswire)
2024-11-18 20:00
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers(Businesswire)
2024-11-07 03:05
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum(Yahoo Finance)
2024-11-05 03:05
Pulmonx to Present at the Stifel 2024 Healthcare Conference(Globenewswire)
2024-11-04 20:55
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know(Yahoo Finance)
2024-10-30 19:00
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...(Yahoo Finance)
2024-10-30 06:25
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates(Yahoo Finance)
2024-10-30 04:05
Pulmonx Reports Third Quarter 2024 Financial Results(Yahoo Finance)
2024-10-16 04:05
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024(Globenewswire)
2024-09-09 04:05
Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024(Globenewswire)
2024-08-29 04:05
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference(Globenewswire)
2024-08-22 04:05
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference(Globenewswire)
2024-07-31 05:50
Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-07-31 04:05
Pulmonx Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-07-29 04:05
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference(Globenewswire)
2024-07-10 04:05
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024(Globenewswire)
2024-05-21 21:55
How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3%(Zacks)
2024-05-06 05:03
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-05-05 21:55
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?(Zacks)
2024-05-02 21:43
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-05-02 21:43
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript(Yahoo Finance)
2024-05-01 19:37
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-05-01 19:05
Q1 2024 Pulmonx Corp Earnings Call(Yahoo Finance)
2024-05-01 15:38
Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...(Yahoo Finance)
2024-05-01 08:55
LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-01 06:05
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-05-01 05:46
Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses(Yahoo Finance)
2024-05-01 04:05
Pulmonx Reports First Quarter 2024 Financial Results(Globenewswire)
2024-04-10 04:05
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024(Globenewswire)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.